國家衛生研究院 NHRI:Item 3990099045/4706
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 914240      線上人數 : 1319
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/4706


    題名: Outcome of thiazolidinedione use in discharged diabetic patients who were hospitalized for heart failure
    作者: Chou, HY;Huang, WF;Tsai, YW
    貢獻者: Division of Health Policy Research and Development
    摘要: OBJECTIVES: Thiazolidinedione (TZD) was recommended not for patients with moderate and serious heart failures due to the adverse reaction of body fluid retention. Our study investigated the use of TZD by type 2 diabetic patients after they were discharged from hospitalizations for heart failure. METHODS: The cohort observation was based on claims database of Taiwan’s National Health Insurance (NHI) for 2002∼2004. There were4774 diabetic patients who were hospitalized due to heart failure during 2003: 379 TZD users and 4395 non-TZD users. A total of 2692 non-TZD users who used sulfonylurea after discharge were selected as the control group. Cox proportional hazard models were estimated to compared the outcomes of death and readmission to hospitals of TZD users and sulfonylurea users,one year after the time patients were discharged. RESULTS:There were 7.9% of diabetic patients who were hospitalized for heart failure and received TZD treatments. There was no significant difference on readmission over one year after discharge between the two groups. However, among those who used TZDor sulfonylurea less than 60 days, those who used TZD had lower HR of readmission than those who used sulfonylurea (HR0.728, 95% CI 0.551∼0.962). Overall, the HR for death among patients receiving TZD was significant lower than the control group of sulfonylurea users (HR 0.092, 95% CI = 0.022–0.380).CONCLUSIONS: Based on the precautions stated in TZD package inserts, 7.9% of type 2 diabetic patients with heart failure received potentially inappropriate prescriptions. Short term use of TZD significantly reduced hazards ratio in readmission, though long term use of both TZD and sulfonylurea showed no difference on readmission, and the use of TZD significantly reduced the hazard of death.
    日期: 2006-11
    關聯: Value in Health. 2006 Nov-Dec;9(6):A342.
    Link to: http://dx.doi.org/10.1016/S1098-3015(10)63634-0
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1098-3015&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000240922000487
    顯示於類別:[蔡憶文(1999-2010)] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000240922000487.pdf58KbAdobe PDF607檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋